<DOC>
	<DOCNO>NCT02595034</DOCNO>
	<brief_summary>This study evaluate therapeutic equivalence safety Clindamycin Benzoyl Peroxide Gel 1 % /5 % BenzaClin® ( clindamycin 1 % /benzoyl peroxide 5 % ) Topical Gel</brief_summary>
	<brief_title>A Study CLBG Benzoyl Peroxide Gel 1 % /5 % BenzaClin® Gel Treatment Acne Vulgaris</brief_title>
	<detailed_description>The objective study evaluate therapeutic equivalence safety Clindamycin Benzoyl Peroxide Gel 1 % /5 % ( Taro Pharmaceuticals Inc. ) BenzaClin® ( clindamycin 1 % /benzoyl peroxide 5 % ) Topical Gel ( Sanofi Aventis , US ) treatment acne vulgaris demonstrate superiority efficacy test reference product placebo control</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>1 . Healthy male nonpregnant female age ≥ 12 ≤ 40 year clinical diagnosis acne vulgaris . 2 . On face , ≥ 25 noninflammatory lesion ( i.e. , open close comedo ) AND ≥ 20 inflammatory lesion ( i.e. , papule pustule ) AND ≤ 2 nodulocystic lesion ( i.e. , nodule cyst ) . 3 . Investigator 's Global Assessment ( IGA ) acne severity grade 2 , 3 , 4 4 . Willing refrain use topical acne medication antibiotics 10week treatment period . 5 . If female childbearing potential , willing use acceptable form birth control study . Exclusion Criteria 1 . Presence skin condition would interfere diagnosis assessment acne vulgaris ( e.g. , face : rosacea , dermatitis , psoriasis , squamous cell carcinoma , eczema , acneform eruption cause medication , steroid acne , steroid folliculitis , bacterial folliculitis ) . 2 . Excessive facial hair ( e.g . beard , sideburn , moustache , etc . ) would interfere diagnosis assessment acne vulgaris . 3 . History hypersensitivity allergy benzoyl peroxide clindamycin and/or study medication ingredient . 4 . Use within 6 month prior baseline oral retinoids ( e.g . Accutane® ) therapeutic vitamin A supplement great 10,000 units/day ( multivitamin allow ) . 5 . Use le 3 month prior baseline estrogen oral contraceptive ; use therapy must remain constant throughout study . 6 . Use face within 1 month prior baseline study : 1 ) cryodestruction chemodestruction , 2 ) dermabrasion , 3 ) photodynamic therapy , 4 ) acne surgery , 5 ) intralesional steroid , 6 ) xray therapy . 7 . Use within 1 month prior baseline : 1 ) spironolactone , 2 ) systemic steroid , 3 ) systemic antibiotic , 4 ) systemic treatment acne vulgaris ( oral retinoids , require 6month washout ) , 5 ) systemic antiinflammatory agent . 8 . Use within 2 week prior baseline : 1 ) topical steroid , 2 ) topical retinoids , 3 ) topical acne treatment include overthecounter preparation , 4 ) topical antiinflammatory agent , 5 ) medicate cleanser 6 ) topical antibiotic .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>